Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia

We compared two dosing schedules for subcutaneous injections of a low-dose humanized anti-CD20 antibody, veltuzumab, in immune thrombocytopenia. Fifty adults with primary immune thrombocytopenia, in whom one or more lines of standard therapy had failed and who had a platelet count <30×10(9)/L but...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Liebman, Howard A., Saleh, Mansoor N., Bussel, James B., Negrea, O. George, Horne, Heather, Wegener, William A., Goldenberg, David M.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5394874/
https://ncbi.nlm.nih.gov/pubmed/27515248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.146738
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados